Tranexamic Acid: Advanced Clinical Insights & Latest Guidelines
Tranexamic acid (TXA) is a synthetic lysine analogue that functions as a potent antifibrinolytic agent by inhibiting plasminogen activation and plasmin activity. This pharmacological mechanism confers its haemostatic efficacy, making it indispensable in various clinical scenarios, including surgical interventions, trauma management, and disorders of excessive fibrinolysis. The widespread adoption of tranexamic acid is attributed to its favourable safety profile, cost-effectiveness, and broad-spectrum applications. Additionally, ongoing research continues to uncover new potential indications for TXA, reinforcing its critical role in haemostasis and reducing mortality and morbidity across various medical disciplines.
 |
| Image source Google |
